SAS Clinical Acceleration on Viya helps life sciences teams scale clinical submissions by automating derivations, embedding validation, and producing submission-ready outputs within a governed, cloud-native environment.
SAS Clinical Acceleration on Viya helps life sciences teams scale clinical submissions by automating derivations, embedding validation, and producing submission-ready outputs within a governed, cloud-native environment.
The regulatory submission process in life sciences is becoming less about assembling documents and more about proving trust. For years, submission readiness was largely treated as an end-stage operational milestone: finalize the analysis, validate the outputs and package everything for regulators. But that model is beginning to break down under
Governance, risk and compliance (GRC) has evolved beyond a control mechanism or regulatory safeguard. In today’s environment, it forms the operational backbone of effective corporate management – enabling organizations to identify risks early, meet regulatory expectations reliably, and ensure that decisions and processes remain transparent and traceable. Yet many organizations still